2015: An Important Year for Advancing Generic Drugs at FDA
By Kathleen “Cook” Uhl MD – At FDA’s Office of Generic Drugs (OGD) in the Center for Drug Evaluation and Research, 2015 was an important year. It was our first full year of operation after vastly expanding our office’s scope and structure
